Unique Pharma Primobolan Unique Lab Test Results

Anabolic Lab
August 23, 2024

Summary

The product PRIMOBOLAN UNIQUE 100MG/ML, manufactured by Unique Pharma, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number UN55337, was submitted by the reseller Opitropin.EU and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis determined the presence of Methenolone Enanthate at a concentration of 99.81 mg/ml, which is 0.19% below the labeled claim of 100 mg/ml, indicating accurate dosing within an acceptable range.

The testing process began on 16 August 2024, with the sample received on 22 August 2024, and analysis completed on 23 August 2024. While the results confirm proper dosing, careful evaluation of reseller-submitted samples is necessary to ensure reliability across all batches. Resellers may select specific batches that meet high standards, potentially affecting the consistency of the product in the market. Independent third-party testing remains crucial for comprehensive verification. This report serves as an educational resource to promote harm reduction and informed decision-making.


Detailed Report

Product Overview

  • Manufacturer: Unique Pharma
  • Product Name: PRIMOBOLAN UNIQUE 100MG/ML
  • Active Ingredient: Methenolone Enanthate
  • Batch Number: UN55337
  • Expiration Date: Not provided
  • Delivery Method: Injectable

Sample Acquisition and Testing

  • Task Number: #47865
  • Testing Ordered: 16 August 2024
  • Sample Received: 22 August 2024
  • Analysis Conducted By: Janoshik Analytical
  • Product Submitted By: Opitropin.EU (Reseller)
  • Analysis Paid For By: Opitropin.EU

Testing Results

  • Specification: 100 mg/ml (as stated on the label)
  • Measured Concentration: 99.81 mg/ml
  • Accuracy: 99.81% (0.19% below the label claim)
  • Variance: -0.19%

Verification Details


Evaluation of Reseller-Submitted Testing

This analysis highlights the accuracy of the tested product but requires careful scrutiny as it was submitted and funded by the reseller Opitropin.EU. Resellers often select the best-performing batches for testing, which might not accurately represent the consistency of products available to consumers. While Janoshik Analytical follows stringent testing protocols, further independent validation across multiple batches would enhance the reliability of these findings.


Conclusion

The analysis confirms that PRIMOBOLAN UNIQUE 100MG/ML is accurately dosed, with a measured concentration of 99.81 mg/ml, which is 0.19% below the labeled claim. While this batch maintains strong quality control, additional testing is advised to ensure consistent dosing across the entire product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed decisions regarding anabolic steroid products.


Disclaimer

This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful insights when critically assessed alongside independent third-party results. Readers are encouraged to use this information responsibly.